GE HealthCare Unveils AI Innovation Lab and Early-Stage Innovations

GE HealthCare’s AI Innovation Lab aims to revolutionize healthcare by developing practical AI solutions. Projects include the Health Companion for real-time treatment recommendations, early detection tools for aggressive breast cancer, and systems to improve radiology workflows, ultimately enhancing patient care.

November 20, 2024

•

1–2 minutes

Sources and References

GE HealthCare. “GE HealthCare Announces AI Innovation Lab Showcasing Five New Research Projects.” GE HealthCare Press Release, 21 Oct. 2024, https://www.gehealthcare.com.

GE HealthCare. “GE HealthCare Launches New AI Innovation Lab.” Medical Product Outsourcing, 18 Nov. 2024, https://www.medicalproductoutsourcing.com.

Healthcare Technology Report. “GE HealthCare Unveils AI Innovation Lab to Advance Medical AI Solutions.” Healthcare Technology Report, 14 Nov. 2024, https://www.thehealthcaretechnologyreport.com.

National Cancer Institute. “Breast Cancer Screening (PDQ®)–Health Professional Version.” National Cancer Institute, 28 Mar. 2024, https://www.cancer.gov/types/breast/hp/breast-screening-pdq.

National Institutes of Health. “Early Prediction of Lethal Phenotypes in Triple Negative Breast Cancer Using Multiscale, Multi-Modality Platforms.” NIH Reporter, https://reporter.nih.gov/project-details/10883284.

U.S. Food and Drug Administration. “Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices.” FDA.gov, 7 Aug. 2024, https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices.

.